Pragmatic multicentre randomised controlled trial showed that primary trabeculectomy had similar quality of life and safety outcomes and achieved a lower intraocular pressure compared with primary medication in newly diagnosed advanced open-angle glaucoma.
MMC, Mitomycin C; VFQ-25, visual function questionnaire-25; EQ-5D-5L, EuroQol Group’s 5 dimension 5-level health status questionnaire; HUI-3, health utility index mark 3; GUI glaucoma utility index; SITA, Swedish interactive threshold algorithm; QOL, quality of life; IOP, intraocular pressure.
Reference to original article: King AJ, Hudson J, Fernie G, Kernohan A, Azuara-Blanco A, Burr J, et al. Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS). BMJ. 2021; 373:n1014. https://doi.org/10.1136/bmj.n1014.
Change history
12 January 2022
thumbnail image on the collection page was not given.
17 February 2022
The image was tagged in XML incorrect as MediaInlineImage.
24 August 2021
A Correction to this paper has been published: https://doi.org/10.1038/s41433-021-01751-3
Author information
Authors and Affiliations
Contributions
CEHF drafted infographic, RGM reviewed final image, CH conceived infographic, drafted infographic and reviewed final image.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: Unfortunately, the family name by Rashmi G. Mathew was written incorrect.
Rights and permissions
About this article
Cite this article
Fang, C.E.H., Mathew, R.G. & Henein, C. Infographic of primary trabeculectomy for advanced glaucoma study (TAGS). Eye 36, 915 (2022). https://doi.org/10.1038/s41433-021-01701-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41433-021-01701-z
